Order Article Reprints

Kuang E, Cross RW, McCavitt-Malvido M, Abelson DM, Borisevich V, Stuart L, Agans KN, Mlakar N, Marimuthu A, Deer DJ, et al. Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic. Pathogens. 2022; 11(6):655. https://doi.org/10.3390/pathogens11060655

Kuang, Erin, Robert W. Cross, Maria McCavitt-Malvido, Dafna M. Abelson, Viktoriya Borisevich, Lauren Stuart, Krystle N. Agans, Neil Mlakar, Arumugapradeep Marimuthu, Daniel J. Deer, and et al. 2022. "Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic" Pathogens 11, no. 6: 655. https://doi.org/10.3390/pathogens11060655

Kuang, E., Cross, R. W., McCavitt-Malvido, M., Abelson, D. M., Borisevich, V., Stuart, L., Agans, K. N., Mlakar, N., Marimuthu, A., Deer, D. J., Shestowsky, W. S., Kim, D., Geisbert, J. B., Zeitlin, L., Moyer, C. L., Roy, C. J., Geisbert, T. W., & Bornholdt, Z. A. (2022). Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic. Pathogens, 11(6), 655. https://doi.org/10.3390/pathogens11060655